BioCentury | Oct 26, 2018
Emerging Company Profile

Karius: Blood will tell

Karius Inc. is diagnosing both blood-borne and deep-seated infections with its Karius Test, which sequences cell-free microbial DNA in blood samples and cuts the run time required in traditional assays. The company spun out of...
BC Week In Review | Jul 13, 2018
Financial News

Nohla adds $11M to series B

Off-the-shelf cell therapy company Nohla Therapeutics Inc. (Seattle, Wash.) raised an additional $11 million on June 11 in the second close of a series B financing, bringing the round’s total to $56 million. New investors...
BC Week In Review | May 18, 2018
Financial News

Arch leads Nohla's $45M series B

Off-the-shelf cell therapy company Nohla Therapeutics Inc. (Seattle, Wash.) raised $45 million on May 15 in a series B round led by existing investor Arch Venture Partners. Also participating were new investors Fidelity Management and...
BC Extra | May 15, 2018
Financial News

Arch leads Nohla's $45M series B

Off-the-shelf cell therapy company Nohla Therapeutics Inc. (Seattle, Wash.) raised $45 million in a series B round led by existing investor Arch Venture Partners. Also participating were new investors Fidelity Management and Celgene Corp. (NASDAQ:CELG)...
Items per page:
1 - 4 of 4